<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="64201">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270125</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-Nanoparticles</org_study_id>
    <secondary_id>2 RVO-FNOs/2013</secondary_id>
    <nct_id>NCT02270125</nct_id>
  </id_info>
  <brief_title>Nanoparticles in Nasal Mucosa</brief_title>
  <official_title>The Role of Nanoparticles in Inflammatory Changes of the Nasal Mucosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VSB - Technical University of Ostrava</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective study is to evaluate presence and quantity of nano-sized
      particles and interindividual differences in their distribution and elemental composition in
      human nasal mucosa obtained by mucotomy in patients diagnosed with chronic hypertrophic
      rhinosinusitis and to compare the obtained results with control specimen obtained from
      stillborn children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Samples of nasal mucosa are obtained by mucotomy in general anesthaesia from adult patients
      with chronic hypertrophic rhinosinusitis. Each tissue sample is divided into 4 parts based
      on the distance from the nostrils and is dehydrated, thinly sliced and mounted on glass
      slides. Then the tissue is analyzed with scanning electron microscopy (SEM) and Raman
      microspectroscopy (RMS) to detect solid particles and characterize the morphology and
      compositions of the detected particles. A novel method of quantification of distribution of
      the particles has been designed and used to evaluate interindividual differences in
      distribution of the particles. History of employment is obtained from the patients and the
      data are compared with the findings in the tissue samples.

      The data acquired from the group of adult patients are compared with the results obtained
      from a group of control specimen of nasal mucosa harvested from stillborn children. It is
      presumed that no nano particles will be present in the stillborn children specimen since the
      mucosa was not exposed to airborne particles.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection and characterisation of nano particles</measure>
    <time_frame>36 months</time_frame>
    <description>Morphology characterization and elemental composition of the particles found in the nasal mucosa assessed with SEM (Quanta FEG 450, FEI) with X-ray microanalysis APOLLO X (EDAX) and SEM Philips XL 30 operating at 30 keV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The presence of nano particles in the nasal mucosa obtained from stillborn children</measure>
    <time_frame>36 months</time_frame>
    <description>Confirmation of the presence of nano particle in the nasal mucosa obtained from stillborn children (Yes/No).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Chronic Hypertrophic Rhinosinusitis</condition>
  <condition>Chronic Polypous Rhinosinusitis</condition>
  <arm_group>
    <arm_group_label>Adult patients with chronic rhino sinusitis</arm_group_label>
    <description>Group of adult patients indicated for mucotomy due to chronic hypertrophic rhinosinusitis, with or without polyposis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stillborn children</arm_group_label>
    <description>Control group of stillborn children whose nasal mucosa was not exposed to airborne particles</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mucotomy</intervention_name>
    <description>Surgical removal of hypertrophic mucosa of the inferior nasal turbinate by cold-steel instruments under endoscopic control, under general anaesthesia</description>
    <arm_group_label>Adult patients with chronic rhino sinusitis</arm_group_label>
    <arm_group_label>Stillborn children</arm_group_label>
    <other_name>turbinoplasty</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      nasal mucosa of the inferior nasal turbinate obtained by mucotomy in adult pacients nasal
      mucosa of the inferior nasal turbinate obtained by mucotomy in stillborn children
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with chronic hypertrophic rhinosinusitis, with or without polyposis
        Stillborn children
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic hypertrophic rhihosinusitis without polyposis non responsive to conservative
             treatment for at least six months

          -  chronic hypertrophic rhihosinusitis with polyposis non responsive to conservative
             treatment for at least six months

          -  age between 19 and 64 years of age

          -  signed informed consent of the patient

          -  stillborn children born after 28th week of gestation

        Exclusion Criteria:

        - non-signing of the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lenka Čábalová, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava, Medical Faculty of the Ostrava University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Václav Procházka, MD,PhD,MSc</last_name>
    <phone>+42059737</phone>
    <phone_ext>2510</phone_ext>
    <email>vaclav.prochazka@fno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiří Hynčica</last_name>
    <phone>+420597372587</phone>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanotechnology Centre, VSB-Technical University Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>708 33</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Čabanová, Mgr.</last_name>
      <phone>+420597321557</phone>
      <email>kristina.cabanova@vsb.cz</email>
    </contact>
    <contact_backup>
      <last_name>Jana Kukutschová, doc., Ing., PhD</last_name>
      <phone>+420597321557</phone>
      <email>jana.kukutschova@vsb.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Kristina Čabanová, Mgr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jana Kukutschová, doc.Ing.PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>708 52</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Hyncica, Bc.</last_name>
      <phone>+420597372510</phone>
      <email>jiri.hyncica@fno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Vaclav Prochazka, MD,PhD,MSc</last_name>
      <phone>+420597372544</phone>
      <email>angio@vol.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Lenka Čábalová, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karol Zeleník, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pavel Komínek, prof.,MD,PhD,MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jana Dvořáčková, doc.,MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hana Bielniková, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <reference>
    <citation>Zeleník K, Kukutschová J, Dvořáčková J, Bielniková H, Peikertová P, Cábalová L, Komínek P. Possible role of nano-sized particles in chronic tonsillitis and tonsillar carcinoma: a pilot study. Eur Arch Otorhinolaryngol. 2013 Feb;270(2):705-9. doi: 10.1007/s00405-012-2069-5. Epub 2012 Jun 8.</citation>
    <PMID>22678622</PMID>
  </reference>
  <reference>
    <citation>Dvorackova J, Bielnikova H, Kukutschova J, Peikertova P, Filip P, Zelenik K, Kominek P, Uvirova M, Pradna J, Cermakova Z, Dvoracek I. Detection of nano- and micro-sized particles in routine biopsy material - pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar;159(1):87-92. doi: 10.5507/bp.2012.104. Epub 2012 Dec 10.</citation>
    <PMID>23235723</PMID>
  </reference>
  <reference>
    <citation>Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005 Jul;113(7):823-39. Review. Erratum in: Environ Health Perspect. 2010 Sep;118(9):A380.</citation>
    <PMID>16002369</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 13, 2017</lastchanged_date>
  <firstreceived_date>October 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nasal mucosa</keyword>
  <keyword>chronic hypertrophic rhinosinusitis</keyword>
  <keyword>mucotomy</keyword>
  <keyword>nanoparticles</keyword>
  <keyword>scanning electron microscopy</keyword>
  <keyword>Raman microspectroscopy</keyword>
  <keyword>nasal polyposis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
